Global Ovarian Cysts Market Growth (Status and Outlook) 2023-2029

Global Ovarian Cysts Market Growth (Status and Outlook) 2023-2029

An ovarian cyst is a fluid-filled sac within the ovary. Often they cause no symptoms. Occasionally they may produce bloating, lower abdominal pain, or lower back pain. The majority of cysts are harmless. If the cyst either breaks open or causes twisting of the ovary, it may cause severe pain. This may result in vomiting or feeling faint.

LPI (LP Information)' newest research report, the “Ovarian Cysts Industry Forecast” looks at past sales and reviews total world Ovarian Cysts sales in 2022, providing a comprehensive analysis by region and market sector of projected Ovarian Cysts sales for 2023 through 2029. With Ovarian Cysts sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Ovarian Cysts industry.

This Insight Report provides a comprehensive analysis of the global Ovarian Cysts landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Ovarian Cysts portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Ovarian Cysts market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Ovarian Cysts and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Ovarian Cysts.

The global Ovarian Cysts market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

Most women of reproductive age develop small cysts each month, and large cysts that cause problems occur in about 8% of women before menopause. Ovarian cysts are present in about 16% of women after menopause and if present are more likely to be cancer. Benign ovarian cysts are common in asymptomatic premenarchal girls and found in approximately 68% of ovaries of girls 2–12 years old and in 84% of ovaries of girls 0–2 years old. Most of them are smaller than 9 mm while about 10-20% are larger macrocysts. While the smaller cysts mostly disappear within 6 months the larger ones appear to be more persistent.

This report presents a comprehensive overview, market shares, and growth opportunities of Ovarian Cysts market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Functional Cysts
Non-Functional Cysts

Segmentation by application
Hospital
Clinic
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Pfizer
Teva Pharmaceutical Industries
Quest Diagnostics
Novartis
General Electric
Merck
Boston Scientific
Medtronic

Please note: The report will take approximately 2 business days to prepare and deliver.